Biolase Inc
(BIOLQ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 19,049 | 1,051 | -1,281 | -3,728 | -4,790 |
| Depreciation Amortization | 401 | 246 | 165 | 166 | 110 |
| Income taxes - deferred | -11,950 | N/A | N/A | N/A | N/A |
| Accounts receivable | -1,036 | -3,084 | -1,441 | -530 | N/A |
| Other Working Capital | -1,279 | -1,006 | -285 | -717 | 1,660 |
| Other Operating Activity | 1,329 | 3,205 | 1,766 | 1,031 | 1,130 |
| Operating Cash Flow | $6,514 | $412 | $-1,076 | $-3,778 | $-1,890 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -455 | -478 | 2,107 | -1,069 | -60 |
| Net Acquisitions | -1,825 | N/A | N/A | N/A | 0 |
| Purchase Sale Intangibles | N/A | N/A | -10 | N/A | N/A |
| Other Investing Activity | 0 | 0 | -10 | 0 | 240 |
| Investing Cash Flow | $-2,280 | $-478 | $2,097 | $-1,069 | $180 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,819 | 275 | 59 | 450 | N/A |
| Debt Repayment | -1,148 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 3,577 | 1,035 | 803 | 5,651 | N/A |
| Other Financing Activity | -2,249 | -117 | -1,215 | -433 | 2,470 |
| Financing Cash Flow | $2,999 | $1,193 | $-353 | $5,668 | $2,470 |
| Exchange Rate Effect | 3 | 78 | N/A | N/A | 0 |
| Beginning Cash Position | 3,875 | 2,670 | 2,002 | 1,181 | 420 |
| End Cash Position | 11,111 | 3,875 | 2,670 | 2,002 | 1,180 |
| Net Cash Flow | $7,236 | $1,205 | $668 | $821 | $750 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,514 | 412 | -1,076 | -3,778 | -1,890 |
| Capital Expenditure | -455 | -478 | -154 | -1,069 | N/A |
| Free Cash Flow | 6,059 | -66 | -1,230 | -4,847 | -1,890 |